Skip to main
LNTH
LNTH logo

Lantheus Holdings (LNTH) Stock Forecast & Price Target

Lantheus Holdings (LNTH) Analyst Ratings

Based on 6 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Lantheus Holdings Inc is experiencing a positive upward trajectory in the precision diagnostics market, particularly with its product POSLUMA, which is projected to achieve high-single-digit revenue and unit share in PSMA PET imaging by the first quarter of 2025, a notable increase from its current market position. The recent enhancements to the Pylarify formulary, which will increase batch sizes by approximately 50%, along with three years of TPT eligibility, are anticipated to significantly boost growth for Pylarify starting in the fourth quarter of 2026. Additionally, there are expectations of improved unit and price growth in the third quarter of 2026, setting the stage for further market share recovery and development in the latter part of the year.

Bears say

Lantheus Holdings Inc has experienced a decline in its growth trajectory, with its two-year growth profile now lagging behind that of its profitable SMID MedTech peers due to lowered PYL growth forecasts for 2025-2026. The company's Pylarify product reported revenues of $260 million, reflecting an 8% year-over-year decrease and a significant shortfall of approximately $14 million compared to consensus estimates. Additionally, there has been a disappointing unit growth rate of only 2% year-over-year, coupled with a 10% price headwind in the latest quarter, further exacerbating the negative financial outlook.

Lantheus Holdings (LNTH) has been analyzed by 6 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Lantheus Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Lantheus Holdings (LNTH) Forecast

Analysts have given Lantheus Holdings (LNTH) a Buy based on their latest research and market trends.

According to 6 analysts, Lantheus Holdings (LNTH) has a Buy consensus rating as of Oct 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $74.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $74.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Lantheus Holdings (LNTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.